Kushtrim Kryeziu invited speaker at Precision Medicine meeting in Copenhagen
The European Haematology Association and the Society for Functional Precision Medicine held their first joint meeting on Precision Medicine in Copenhagen September 25th – 27th. Kushtrim Kryeziu was invited speaker to session 1 on precision medicine trials where he presented his work on patient-derived organoids from liver metastases, discussing tumor heterogeneity and the design of the EVIDENT trial.
In this session, the NCI-MATCH and EXALT trials were also presented. The presenters of the three trials were then invited to participate in a panel debate, and Kryeziu presented pros and cons of the EVIDENT trial.
